Subscribe to Newsletter

Content by Rob Coker:

Discovery & Development Drug Discovery

The Blood Clot and the Invisible Frog

| Rob Coker | 2 min read

Groups of tiny glass frogs can sleep on a leaf in daylight and go entirely undetected by predators

Discovery & Development Drug Discovery

Close the Care Gap

| Rob Coker | 9 min read

UICC CEO Cary Adams gives his insights into the challenges of getting cancer treatment to people in low- and middle-income countries.

Discovery & Development Drug Discovery

AI Versus AMR

| Rob Coker | 8 min read

MIT scientists believe the future is bright for antibiotics discovery

Business & Regulation Digital Technologies

Immunization Versus Ignorance

| Rob Coker | 4 min read

Who do we blame for the return of polio?

Manufacture Marketing

Take Another Look

| Rob Coker | 4 min read

Genentech goes beyond pharmaceutical manufacturing in its work with members of the SMA community. Michael Dunn explains

Business & Regulation Marketing

#MemeTeam

| Rob Coker | 4 min read

For any organization, one ill-timed tweet can create enormous backlash.

Discovery & Development Advanced Medicine

Between the Gut and the Stars

| Rob Coker | 4 min read

CEO and Founder of EnteroBiotix James McIllroy shares the wonders of manipulating our microbial passengers.

Manufacture Process Control

The Human Cost of Poor Practice

| Rob Coker | 2 min read

A growing number of deaths linked to pediatric medicines prompts the WHO to investigate “unacceptable” levels of APIs.

Discovery & Development Clinical Trials

Positive Opinion for Regeneron’s Libtayo

| Rob Coker | 3 min read

Regeneron Pharmaceuticals’ Israel Lowy explains how a positive CHMP opinion can become good news for cancer patients

Manufacture Small Molecules

From Bread to Blood

| Rob Coker | 4 min read

How critical anti-cancer drugs can be sustainably developed from genetically engineered baker’s yeast.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register